These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1117518)

  • 1. Treatment of multiple superficial papillary tumors of the bladder by intracavitary yttrium-90.
    Durrant KR; Laing AH
    J Urol; 1975 Apr; 113(4):480-2. PubMed ID: 1117518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late results of cystectomy in carcinoma of the urinary bladder.
    Stadie G; Kuhne U
    Int Urol Nephrol; 1971; 3(4):379-87. PubMed ID: 5154868
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of multiple superficial transitional cell carcinoma of the bladder with intravesical yttrium-90.
    Alcock CJ; Durrant KR; Smith JC; Fellows GJ
    Br J Urol; 1986 Jun; 58(3):287-9. PubMed ID: 3719249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long term results of telecobalt therapy of malignant bladder tumors].
    Savino G
    Minerva Radiol; 1968 Dec; 13(12):793-7. PubMed ID: 5743159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intracavitary radiotherapy with Co60 pearls in the treatment of vesical neoplasms].
    Bono F; Cella C; Maver A; Morselli V
    Radiobiol Radioter Fis Med; 1967; 22(6):388-407. PubMed ID: 5609895
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined intracavitary and external beam irradiation for superficial transitional cell carcinoma of the bladder: an alternative to cystectomy for patients with recurrence after intravesical chemotherapy.
    Russell KJ; Koh WJ; Russell AH; Griffin BR; Markette KL; Tong DY; Griffin TW
    J Urol; 1989 Jan; 141(1):30-2. PubMed ID: 2491760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression.
    Herr HW; Badalament RA; Amato DA; Laudone VP; Fair WR; Whitmore WF
    J Urol; 1989 Jan; 141(1):22-9. PubMed ID: 2908949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on intracavitary radiation in the treatment of bladder tumors.
    Hewitt CB; Babiszewski JF; Antunez AR
    J Urol; 1981 Sep; 126(3):323-5. PubMed ID: 7277590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BCG and radiotherapy: the compatibility of 2 conservative treatments for cancer of the urinary bladder].
    Sánchez-Martín FM; Palou Redorta J; Regalado Pareja R; Rubio Briones J; Villavicencio Mavric H; Vicente Rodríguez J
    Arch Esp Urol; 1999 Sep; 52(7):749-58. PubMed ID: 10540765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma in situ of the urinary bladder. Effect of associated neoplastic lesions on clinical course and treatment.
    Fukui I; Yokokawa M; Sekine H; Yamada T; Hosoda K; Ishiwata D; Oka K; Sarada T; Tohma T; Yamada T
    Cancer; 1987 Jan; 59(1):164-73. PubMed ID: 3791145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2 cases of profuse hematuria after irradiation].
    Wildbolz E; Mischol HR
    J Urol Nephrol (Paris); 1970 Dec; 76(12):286-7. PubMed ID: 5523202
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation-induced cystitis following intracavitary irradiation for superficial bladder cancer.
    Maatman TJ; Novick AC; Montague DK; Levin HS
    J Urol; 1983 Aug; 130(2):338-9. PubMed ID: 6876286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical study of G3 superficial bladder cancer without concomitant CIS treated with conservative therapy.
    Saika T; Tsushima T; Nasu Y; Arata R; Kaku H; Kusaka N; Kumon H
    Jpn J Clin Oncol; 2002 Nov; 32(11):461-5. PubMed ID: 12499418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of the therapy of papillary bladder tumors. II. The results of radiotherapy optimization trials with dosage distribution over time].
    Kob D; Arndt J; Albert L; Kriester A; Herrmann S
    Radiobiol Radiother (Berl); 1979 Aug; 20(4):499-510. PubMed ID: 118479
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Crhomosomes of patients treated with yttrium-90.
    Jalava S; Salonius AL
    Lancet; 1974 Apr; 1(7861):807. PubMed ID: 4132739
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of low grade papillary bladder tumors.
    Herr HW; Donat SM; Reuter VE
    J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of muscle-infiltrating bladder cancer: prospective experience.
    Herr HW
    J Urol; 1987 Nov; 138(5):1162-3. PubMed ID: 3669160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course.
    Takashi M; Sakata T; Murase T; Hamajima N; Miyake K
    Nagoya J Med Sci; 1991 Mar; 53(1-4):1-8. PubMed ID: 1805133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.